Treatment of Alopecia Areata With Dupilumab

Last Updated:
04/24/2020
Status:
Active/Fully Enrolled
Country:
United States
Eligibility:
Age 18+; diagnosed with alopecia areata
Drug:
Dupilumab
Administration:
Injection
Sponsor: 
Icahn School of Medicine at Mount Sinai
Link:
ClinicalTrials.gov

Researchers at The Rockefeller University are conducting a study to test an injectable treatment for alopecia areata.

You may be eligible if you:
  • Are at least 18 years of age
  • Have had moderate to severe alopecia areata (at least 30% hair loss) for at least 6 months
  • Are willing to consider injectable treatment
  • Do not have HIV
Participation includes:
  • 16 visits over 18 months
  • Receipt of study medication
  • Blood work
  • Skin biopsies (required)
Compensation will be provided.

If you are interested, please contact the Recruitment Office at 1-800-RUCARES (1-800-782-2737) or RUCARES@Rockefeller.edu. 

Location: 

The Rockefeller University
Laboratory for Investigative Dermatology 
New York, New YorK